Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
LEUTHOLD GROUP, LLC ANEW ProShares MSCI Transformational Changes ETF 13G 5.1% 2y
EcoR1 Capital, LLC THRD Third Harmonic Bio, Inc. Common Stock 13G/A 7.9% 2y
RA CAPITAL MANAGEMENT, L.P. EYPT EyePoint, Inc. 13G/A 6.1% 2y
Clal Insurance Enterprises Holdings Ltd TSEM Tower Semiconductor Ltd 13G/A 5.3% 2y
Orbis Investment Management Limited ARNC Arconic Corporation 13G/A 0% 2y
BROWNING WEST LP SGI Somnigroup International Inc. 13G/A 7.32% 2y
TIAA-CREF Investment Management, LLC HUYA HUYA Inc. 13G/A 6.75% 2y
Antara Capital LP VRM Vroom, Inc. 13G/A 0% 2y
Driehaus Capital Management LLC BLFY Blue Foundry Bancorp 13G/A 6.81% 2y
T. Rowe Price Investment Management, Inc. VBTX Veritex Holdings, Inc. 13G 8.6% 2y
PERCEPTIVE ADVISORS LLC CYPH Cypherpunk Technologies Inc. 13G/A 4% 2y
AMERIPRISE FINANCIAL INC APEI American Public Education Inc 13G 5.02% 2y
ARMISTICE CAPITAL, LLC DCPH Deciphera Pharmaceuticals, Inc. Common Stock 13G/A 6.49% 2y
EcoR1 Capital, LLC ACET Adicet Bio, Inc. 13G/A 0% 2y
ATW OPPORTUNITIES MASTER FUND II LP ECDA ECD Automotive Design, Inc. 13G/A 7.4% 2y
Riva Ridge Capital Management LP HDSN Hudson Technologies Inc 13G/A 3.7% 2y
Roche Finance Ltd TRDA Entrada Therapeutics, Inc. 13G/A 8.2% 2y
LIGHT STREET CAPITAL MANAGEMENT, LLC NRDY Nerdy Inc. 13G/A 0.4% 2y
Fourthstone LLC EBMT Eagle Bancorp Montana, Inc. 13G 5.51% 2y
Lytton, Laurence W. ALIM Alimera Sciences, Inc. 13G/A 4.2% 2y
New Enterprise Associates 13, L.P. SGMT Sagimet Biosciences Inc. 13G 6.6% 2y
Vinod Khosla GTLB Gitlab Inc. 13G/A 9.1% 2y
Kynam Capital Management, LP SNDX Syndax Pharmaceuticals Inc 13G 6.67% 2y
GLAZER CAPITAL, LLC ARYD ARYA Sciences Acquisition Corp IV Class A Odinary Shares 13G/A 11.8% 2y
Kwok Hang Ng BLZE Backblaze, Inc. 13G/A 5.2% 2y
ALLIANCEBERNSTEIN L.P. HXL Hexcel Corp 13G/A 6.2% 2y
GLAZER CAPITAL, LLC SLAMF Slam Corp. 13G/A 1.1% 2y
Smilodon Capital, LLC PEGR Project Energy Reimagined Acquisition Corp. Class A Ordinary Share 13G/A 30.2% 2y
Granahan Investment Management, LLC LQDT Liquidity Services Inc 13G/A 1.03% 2y
MONTERUBELLO S.S. ZGN Ermenegildo Zegna N.V. 13G/A 59.8% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC HIO Western Asset High Income Opportunity Fund Inc. 13G/A 5.25% 2y
HARRIS ASSOCIATES L P THO Thor Industries Inc 13G/A 5.03% 2y
PERCEPTIVE ADVISORS LLC ALDX Aldeyra Therapeutics, Inc. 13G/A 14.6% 2y
Cubist Systematic Strategies, LLC BWAQ Blue World Acquisition Corporation Class A Ordinary Shares 13G/A 0% 2y
VIKING GLOBAL INVESTORS LP NAMS NewAmsterdam Pharma Co N.V. 13G/A 9.7% 2y
T. Rowe Price Investment Management, Inc. PFSI PennyMac Financial Services, Inc. 13G 9.8% 2y
CANADA PENSION PLAN INVESTMENT BOARD NABL N-able, Inc. 13G/A 5.1% 2y
T. Rowe Price Investment Management, Inc. BKU BankUnited, Inc. 13G/A 10% 2y
Nantahala Capital Management, LLC NVNO enVVeno Medical Corp 13G 9.9% 2y
EVERGREEN CAPITAL MANAGEMENT LLC ROYT PACIFIC COAST OIL TRUST 13G/A 8.6% 2y
TANG CAPITAL MANAGEMENT, LLC ACET Adicet Bio, Inc. 13G/A 7.8% 2y
Ayrton Capital LLC VSEE Vsee Health, Inc. 13G 5.3% 2y
Barbara Robinson Buckland SCHL Scholastic Corp 13G 7.2% 2y
Alyeska Investment Group, L.P. NMRD Nemaura Medical, Inc. Common Stock 13G 9.99% 2y
Timothy Nufire BLZE Backblaze, Inc. 13G/A 5.5% 2y
Teachers Advisors, LLC HUYA HUYA Inc. 13G/A 6.75% 2y
John P. Szabo, Jr. GAIA Gaia, Inc 13G/A 9.8% 2y
Deep Track Capital, LP ALLK Allakos Inc. 13G/A 2.87% 2y
ARMISTICE CAPITAL, LLC CYTH Cyclo Therapeutics, Inc. Common Stock 13G/A 4.99% 2y
Robert Taub NYXH Nyxoah SA 13G/A 11.8% 2y